Lifeline Biotechnologies Inc (LLBO)

[SquirrelCage]

I don't blame anyone invested for years to be somewhat skeptical when they hear repetitive news or conflicting information. However, to be locked into a negative spin seems like a reason to not waste anymore time on this stock - whether it's investing in it or posting messages constantly hammering away on anything positive.

For Deep, you could have simply gone to Cyrcadia's website and got the exact same information that was provided on Pitchbook (which was something posted quite a while back by another long - before, as was said, the CA deal) instead of wasting time digging on Google to prove your dilution point. The "Investors" tab states the stages they planned for private fund raising:

•Cyrcadia, Inc. has raised historical Seed financing of $4.5M+ through combination Seed Stage Investors, Angels and Convertible Note contributions.
•Cyrcadia is opening a $6.5 Series A funding for expansion of clinical trials to Stanford University and commercial product release.
•For additional Information please contact: Rob Royea, CEO at: [e-mail]

When the Cyrcadia Asia deal was made, they purchased CI shares at $1 per. Did that take care of the offering, along with other interested investors? 830,000 x 2 (warrants) = 1,660,000 shares.

Cyrcadia, Inc. received the following compensation for the license to Cyrcadia Asia Limited: An $830,000 Cyrcadia, Inc. equity investment at $1.00 per share with an equal $1.00 warrant; a $1,050,000 promissory note; Cyrcadia Asia, Limited assumed approximately $3,000,000 in product development costs for the Bluetooth ™ and added sensor costs. Cyrcadia, Inc. received an equity interest in Cyrcadia Asia, Limited. Additionally, Cyrcadia Asia Limited assumed approximately $500,000 of Cyracdia, Inc.'s annual general and administrative expenses. Cyrcadia Asia Limited will license Cyrcadia, Inc. for the developed Bluetooth™ and additional sensors products once development is completed. The transaction is valued at approximately $5 million.

Lifeline initially reported a 45% interest in Cyrcadia Health and now, per them on the most recent update, it's 40%. Does that account for the dilution you're worried about?

The Company recently transferred breast cancer detection technology to Cyrcadia, Inc. in exchange for 4,670,000 shares of Cyrcadia, Inc. common stock and a $110,000 cash and $220,000 promissory note. The additional 4,670,000 shares added to Lifeline's original 8,000,000 shares totals 12,670,000 shares. Lifeline's ownership is increased to over 45% of Cyrcadia, Inc., making Lifeline Cyrcadia, Inc.'s largest single shareholder.

I, myself, have a difficult time following the valuation and percentage but know there were different stages of raising at different amounts, which also affects the value. If the next stage was $2/share, we'd own a slightly less percentage of an increased value. I know Change and a couple others boiled it down really well but don't know which posts. Change has a good summation on the board "Pennies to Dollars" (Post 89) and, if willing, could probably repeat the explanation with one post. :) Also, the reminder that Cyrcadia Asia not only coughed cash up but assumed the cost of development and manufacturing, plus other expenses. They were raising funds for that entity, not Cyrcadia, Inc. in the beginning of the year at the Health Tech O2O Summit in Hong Kong: https://www.healthtecho2o.com/speakers-1